Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
2 Jun 2017
Transparency notifications BlackRock, Inc.
Read More
2 Jun 2017
Transparency notification
Read More
29 May 2017
Transparency notification
Read More
23 May 2017
Transparency notification
Read More
23 May 2017
Transparency notifications BlackRock, Inc.
Read More
21 May 2017
UCB and Amgen announce top-line phase 3 data from active-comparator study of Evenity™ (romosozumab) in postmenopausal women with osteoporosis
Read More
17 May 2017
Transparency notification
Read More
27 Apr 2017
UCB's General Meeting of Shareholders
Read More
26 Apr 2017
UCB receives positive CHMP opinion for CIMZIA® (certolizumab pegol) dose dispenser cartridge for use with ava® electronic injection device
Read More
24 Apr 2017
UCB First Three Months Interim Report 2017: UCB with a good start into 2017
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
31
Page
32
Page
33
Page
34
Current page
35
Page
36
Page
37
Page
38
Page
39
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss